BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bruno S, Chiabotto G, Camussi G. Extracellular Vesicles: A Therapeutic Option for Liver Fibrosis. Int J Mol Sci 2020;21:E4255. [PMID: 32549355 DOI: 10.3390/ijms21124255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Šrajer Gajdošik M, Kovač Peić A, Begić M, Grbčić P, Brilliant KE, Hixson DC, Josić D. Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen. IJMS 2022;23:8870. [DOI: 10.3390/ijms23168870] [Reference Citation Analysis]
2 Sun J, Zhang D, Li Y. Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease. Front Physiol 2022;13:909518. [DOI: 10.3389/fphys.2022.909518] [Reference Citation Analysis]
3 Newman LA, Muller K, Rowland A. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04256-8] [Reference Citation Analysis]
4 Hu S, Xing H, Zhang J, Zhu Z, Yin Y, Zhang N, Qi Y, Li YS. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Immunomodulatory Effects and Potential Applications in Intervertebral Disc Degeneration. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/7538025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo L, Guan Y, Liu P, Gao L, Wang Z, Huang S, Peng L, Zhao Z. Chitosan hydrogel, as a biological macromolecule-based drug delivery system for exosomes and microvesicles in regenerative medicine: a mini review. Cellulose. [DOI: 10.1007/s10570-021-04330-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Limongi T, Susa F, Marini M, Allione M, Torre B, Pisano R, di Fabrizio E. Lipid-Based Nanovesicular Drug Delivery Systems. Nanomaterials (Basel) 2021;11:3391. [PMID: 34947740 DOI: 10.3390/nano11123391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
7 Zhou X, Liang Z, Qin S, Ruan X, Jiang H. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells. Mol Biol Rep 2021. [PMID: 34843038 DOI: 10.1007/s11033-021-07008-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chiabotto G, Ceccotti E, Tapparo M, Camussi G, Bruno S. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype. Front Cell Dev Biol 2021;9:777462. [PMID: 34796180 DOI: 10.3389/fcell.2021.777462] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Kim J, Lee SK, Jeong SY, Cho HJ, Park J, Kim TM, Kim S. Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis. J Nanobiotechnology 2021;19:372. [PMID: 34789265 DOI: 10.1186/s12951-021-01120-y] [Reference Citation Analysis]
10 Devaraj E, Perumal E, Subramaniyan R, Mustapha N. Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space. Hepatology 2021. [PMID: 34773651 DOI: 10.1002/hep.32239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Huang YJ, Cao J, Lee CY, Wu YM. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis. Stem Cell Res Ther 2021;12:568. [PMID: 34772443 DOI: 10.1186/s13287-021-02641-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Lee J, Kim SR, Lee C, Jun YI, Bae S, Yoon YJ, Kim OY, Gho YS. Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride. J Extracell Vesicles 2021;10:e12133. [PMID: 34401049 DOI: 10.1002/jev2.12133] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Wu D, Zhu H, Wang H. Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease. Front Physiol 2021;12:707429. [PMID: 34335310 DOI: 10.3389/fphys.2021.707429] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Kim JY, Rhim WK, Yoo YI, Kim DS, Ko KW, Heo Y, Park CG, Han DK. Defined MSC exosome with high yield and purity to improve regenerative activity. J Tissue Eng 2021;12:20417314211008626. [PMID: 33959246 DOI: 10.1177/20417314211008626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang P, Gan Z, Tang L, Zhou L, Huang X, Wang J. Exosomes from microRNA-145-5p-modified HUCB-MSCs attenuate CCl4-induced hepatic fibrosis via down-regulating FSCN1 expression. Life Sci 2021;:119404. [PMID: 33794251 DOI: 10.1016/j.lfs.2021.119404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu WZ, Ma ZJ, Li JR, Kang XW. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res Ther 2021;12:102. [PMID: 33536064 DOI: 10.1186/s13287-021-02153-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
17 Suh JH, Joo HS, Hong EB, Lee HJ, Lee JM. Therapeutic Application of Exosomes in Inflammatory Diseases. Int J Mol Sci 2021;22:1144. [PMID: 33498928 DOI: 10.3390/ijms22031144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
18 Chiabotto G, Pasquino C, Camussi G, Bruno S. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis. Front Cell Dev Biol 2020;8:594794. [PMID: 33425900 DOI: 10.3389/fcell.2020.594794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]